Azintuxizumab (Anti-SLAMF7 / CS1)

Azintuxizumab (Anti-SLAMF7 / CS1) is a monoclonal IgG4 bispecific antibody targeting B-cell maturation antigen (BCMA). It has the potential for the research of relapsed/refractory multiple myeloma (RRMM). MW :140.12 KD.

• Supplier: Selleck Chemicals
• Product #: A3061
• Sku #: A3061-1mg